BofA Securities Maintains Alnylam Pharmaceuticals(ALNY.US) With Buy Rating, Maintains Target Price $307
BofA Securities Maintains Alnylam Pharmaceuticals(ALNY.US) With Buy Rating, Announces Target Price $307
China Merchants Initiates Alnylam Pharmaceuticals at Buy With $360 Price Target
RBC Capital Maintains Alnylam Pharmaceuticals(ALNY.US) With Buy Rating, Maintains Target Price $300
BofA Securities Maintains Alnylam Pharmaceuticals(ALNY.US) With Buy Rating
TD Cowen Maintains Alnylam Pharmaceuticals(ALNY.US) With Buy Rating, Maintains Target Price $282
TD Cowen Sticks to Their Buy Rating for Alnylam Pharma (ALNY)
Alnylam Pharmaceuticals Analyst Ratings
Evercore Maintains Alnylam Pharmaceuticals(ALNY.US) With Buy Rating, Maintains Target Price $260
RBC Capital Maintains Alnylam Pharmaceuticals(ALNY.US) With Buy Rating, Maintains Target Price $300
BofA Securities Maintains Alnylam Pharmaceuticals(ALNY.US) With Buy Rating, Maintains Target Price $307
A Quick Look at Today's Ratings for Alnylam Pharmaceuticals(ALNY.US), With a Forecast Between $275 to $400
Alnylam Pharmaceuticals Is Maintained at Buy by B of A Securities
Alnylam Pharmaceuticals Price Target Raised to $307.00/Share From $295.00 by B of A Securities
A Quick Look at Today's Ratings for Alnylam Pharmaceuticals(ALNY.US), With a Forecast Between $282 to $295
Alnylam Pharma (ALNY) Gets a Buy From TD Cowen
Analysts' Top Healthcare Picks: Alnylam Pharma (ALNY), Eli Lilly & Co (LLY)
Stifel Maintains Alnylam Pharmaceuticals(ALNY.US) With Buy Rating, Maintains Target Price $295
Alnylam Pharmaceuticals Analyst Ratings
H.C. Wainwright Maintains Alnylam Pharmaceuticals(ALNY.US) With Buy Rating, Maintains Target Price $400